Updates
** India's UltraTech Cement ULTC.NS shares up 3.6%
** The cement maker posts a 27% y/y rise in third-quarter consol net profit; net sales up 23% lifted by 15% rise in consol sales volumes
** Stock gets at least 19 TP hikes, at least two rating upgrades since results were released - data compiled by LSEG
RESULTS PROVE AGAIN CO HAS "NO COMPARABLE PEER"
** PhillipCapital India Research ("buy", TP 15,300 rupees): Co "once again proves that there is no comparable peer" to itself "not just in terms of capacity but also in terms of an ability to deliver on strong operating performance despite a challenging business environment"
** Emkay Research ("buy", hikes TP 5% to 14,700 rupees): ULTC been our top pick, we "continue to repose faith on its ability to deliver cost savings and strengthen its pole market share position"
** Systematix Research ("buy", lifts TP 3.6% TO 15,000 rupees): We remain upbeat on stock's growth prospects such as its healthy volume performance, high-capacity utilizations, fortress balance sheet and a mammoth expansion plan that cements co's leadership position further
** Elara Securities ("accumulate", raises TP 3.3% to 14,553 rupees): Co "well-positioned" to outpace industry, supported by improving demand and ramp-up of recently added capacities across organic and inorganic routes
(Reporting by Hritam Mukherjee in Bengaluru)
((Hritam.Mukherjee@thomsonreuters.com;))